Pharmacological research

How fast-acting antidepressants work at the molecular level and new ideas for developing them

Updated

Abstract

Ketamine may produce rapid antidepressant effects by influencing multiple synaptic targets.

  • Conventional antidepressants often require several weeks to show significant effects, and about two-thirds of patients may not respond effectively.
  • Ketamine's antidepressant action involves not only NMDA receptor antagonism but also affects other receptors and channels in the synapse.
  • The mechanisms of ketamine include effects on α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors, adenosine A1 receptors, and L-type calcium channels.
  • Psilocybin, a 5-HT2A receptor agonist, has shown potential for rapid antidepressant effects in both mouse models and clinical studies.
  • The review highlights emerging pharmacological targets for rapid-acting antidepressants, suggesting new directions for future research.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free